The quiet strength in FatPipe FATN business model Investors Pile In 20260507 How Karyopharm Therapeutics KPTI pricing changes flow through to earnings KPTI Q4 2025 Earnings Karyopharm Therapeutics Misses Forecast as Loss Widens Abeona ABEO Competitive Advantages Abeona Therapeutics 2 EPS miss 582M revenue